Table 1 |
||||
|
Wnt-5 heterozygous embryos are more sensitive to wnt-5 MO injection in pancreatic islet formation. |
||||
|
WT |
WT X wnt-5/WT |
|||
|
|
||||
|
trans-block wnt-5 MO |
exon-intron wnt-5 MO |
trans-block wnt-5 MO |
exon-intron wnt-5 MO |
|
|
|
||||
|
% of embryos with abnormal insulin expression |
5 ± 2% |
0% |
46 ± 5% |
52 ± 3% |
|
total # of embryos |
N = 124 |
N = 113 |
N = 53 |
N = 57 |
|
|
||||
|
2 ng of either wnt-5 translation-blocking or exon-intron junction targeting morpholinos were injected into either wild-type embryos or embryos generated from an outcross of a wnt-5 mutant carrier adult. In wild-type embryos, injection of either wnt-5 MO resulted in less than 5% of embryos with scattered insulin expression. However, injection of either wnt-5 MO resulted in about 50% of embryos with scattered insulin expression in embryos obtained from the wnt-5 mutant carrier outcross. |
||||
|
Kim et al. BMC Biology 2005 3:23 doi:10.1186/1741-7007-3-23 |
||||